• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病抑制因子驱动葡萄糖代谢重编程以促进乳腺肿瘤发生。

Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis.

作者信息

Yue Xuetian, Wang Jianming, Chang Chun-Yuan, Liu Juan, Yang Xue, Zhou Fan, Qiu Xia, Bhatt Vrushank, Guo Jessie Yanxiang, Su Xiaoyang, Zhang Lanjing, Feng Zhaohui, Hu Wenwei

机构信息

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

出版信息

Cell Death Dis. 2022 Apr 19;13(4):370. doi: 10.1038/s41419-022-04820-x.

DOI:10.1038/s41419-022-04820-x
PMID:35440095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9018736/
Abstract

LIF, a multifunctional cytokine, is frequently overexpressed in many types of solid tumors, including breast cancer, and plays an important role in promoting tumorigenesis. Currently, how LIF promotes tumorigenesis is not well-understood. Metabolic reprogramming is a hallmark of cancer cells and a key contributor to cancer progression. However, the role of LIF in cancer metabolic reprogramming is unclear. In this study, we found that LIF increases glucose uptake and drives glycolysis, contributing to breast tumorigenesis. Blocking glucose uptake largely abolishes the promoting effect of LIF on breast tumorigenesis. Mechanistically, LIF overexpression enhances glucose uptake via activating the AKT/GLUT1 axis to promote glycolysis. Blocking the AKT signaling by shRNA or its inhibitors greatly inhibits glycolysis driven by LIF and largely abolishes the promoting effect of LIF on breast tumorigenesis. These results demonstrate an important role of LIF overexpression in glucose metabolism reprogramming in breast cancers, which contributes to breast tumorigenesis. This study also reveals an important mechanism underlying metabolic reprogramming of breast cancers, and identifies LIF and its downstream signaling as potential therapeutic targets for breast cancers, especially those with LIF overexpression.

摘要

白血病抑制因子(LIF)是一种多功能细胞因子,在包括乳腺癌在内的多种实体瘤中经常过度表达,在促进肿瘤发生中起重要作用。目前,LIF如何促进肿瘤发生尚不清楚。代谢重编程是癌细胞的一个标志,也是癌症进展的关键因素。然而,LIF在癌症代谢重编程中的作用尚不清楚。在本研究中,我们发现LIF增加葡萄糖摄取并驱动糖酵解,促进乳腺肿瘤发生。阻断葡萄糖摄取在很大程度上消除了LIF对乳腺肿瘤发生的促进作用。机制上,LIF过表达通过激活AKT/葡萄糖转运蛋白1(GLUT1)轴增强葡萄糖摄取,从而促进糖酵解。通过短发夹RNA(shRNA)或其抑制剂阻断AKT信号通路可大大抑制LIF驱动的糖酵解,并在很大程度上消除LIF对乳腺肿瘤发生的促进作用。这些结果证明LIF过表达在乳腺癌葡萄糖代谢重编程中起重要作用,这有助于乳腺肿瘤发生。本研究还揭示了乳腺癌代谢重编程的一个重要机制,并确定LIF及其下游信号通路为乳腺癌,尤其是LIF过表达乳腺癌的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/c54df0663e80/41419_2022_4820_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/7989de6f1c56/41419_2022_4820_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/1545d54fc449/41419_2022_4820_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/913174f4fbe2/41419_2022_4820_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/e98814d93f55/41419_2022_4820_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/13b3b08f0900/41419_2022_4820_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/d7e8b9de7dc1/41419_2022_4820_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/c54df0663e80/41419_2022_4820_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/7989de6f1c56/41419_2022_4820_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/1545d54fc449/41419_2022_4820_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/913174f4fbe2/41419_2022_4820_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/e98814d93f55/41419_2022_4820_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/13b3b08f0900/41419_2022_4820_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/d7e8b9de7dc1/41419_2022_4820_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38f/9018736/c54df0663e80/41419_2022_4820_Fig7_HTML.jpg

相似文献

1
Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis.白血病抑制因子驱动葡萄糖代谢重编程以促进乳腺肿瘤发生。
Cell Death Dis. 2022 Apr 19;13(4):370. doi: 10.1038/s41419-022-04820-x.
2
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway.白血病抑制因子通过AKT-雷帕霉素靶蛋白(mTOR)信号通路促进乳腺癌的肿瘤发生和转移。
Oncotarget. 2014 Feb 15;5(3):788-801. doi: 10.18632/oncotarget.1772.
3
Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.突变型 KRAS 下调白血病抑制因子 (LIF) 的受体,以增强胰腺癌和肺癌中的糖酵解特征。
Mol Cancer Res. 2021 Aug;19(8):1283-1295. doi: 10.1158/1541-7786.MCR-20-0633. Epub 2021 Apr 30.
4
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.转化生长因子-β(TGF-β)重塑肿瘤相关成纤维细胞的代谢以促进肿瘤生长:将 TGF-β 信号与“Warburg-like”肿瘤代谢和 L-乳酸生成联系起来。
Cell Cycle. 2012 Aug 15;11(16):3019-35. doi: 10.4161/cc.21384. Epub 2012 Aug 9.
5
Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.白血病抑制因子通过STAT3依赖的miR-21诱导促进上皮-间质转化。
Oncotarget. 2016 Jan 26;7(4):3777-90. doi: 10.18632/oncotarget.6756.
6
ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.ATM 抑制剂 KU-55933 通过阻断 Akt 持续激活的葡萄糖转运蛋白 1(GLUT1)介导的葡萄糖摄取,诱导具有侵袭性的癌细胞凋亡并抑制其迁移。
FASEB J. 2021 Apr;35(4):e21264. doi: 10.1096/fj.202001415RR.
7
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.白血病抑制因子通过PI3K/AKT依赖的Mcl-1激活保护胆管癌细胞免受药物诱导的凋亡。
Oncotarget. 2015 Sep 22;6(28):26052-64. doi: 10.18632/oncotarget.4482.
8
Differential effects of Akt isoforms on somatic cell reprogramming.Akt亚型对体细胞重编程的不同影响。
J Cell Sci. 2014 Sep 15;127(Pt 18):3998-4008. doi: 10.1242/jcs.150029. Epub 2014 Jul 18.
9
Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest.白血病抑制因子通过诱导 G1 期阻滞抑制胃癌的增殖。
J Cell Physiol. 2019 Apr;234(4):3613-3620. doi: 10.1002/jcp.27083. Epub 2018 Nov 22.
10
Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.通过Myc抑制TXNIP实现三阴性乳腺癌中的代谢重编程
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5425-30. doi: 10.1073/pnas.1501555112. Epub 2015 Apr 13.

引用本文的文献

1
Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models.在小鼠胰腺癌模型中,阻断白血病抑制因子(LIF)和程序性死亡受体配体1(PD-L1)可增强立体定向体部放疗(SBRT)的抗肿瘤疗效。
J Immunother Cancer. 2025 May 7;13(5):e010820. doi: 10.1136/jitc-2024-010820.
2
Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis.靶向白血病抑制因子/白血病抑制因子受体轴通过促进铁死亡来减少炎性乳腺癌的生长。
Cancers (Basel). 2025 Feb 25;17(5):790. doi: 10.3390/cancers17050790.
3
Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes.

本文引用的文献

1
The emerging role of leukemia inhibitory factor in cancer and therapy.白血病抑制因子在癌症和治疗中的新作用。
Pharmacol Ther. 2021 May;221:107754. doi: 10.1016/j.pharmthera.2020.107754. Epub 2020 Nov 28.
2
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.葡萄糖转运蛋白1(GLUT1)抑制可阻断RB1阳性三阴性乳腺癌的生长。
Nat Commun. 2020 Aug 21;11(1):4205. doi: 10.1038/s41467-020-18020-8.
3
LIF is essential for ISC function and protects against radiation-induced gastrointestinal syndrome.LIF 对于 ISC 功能至关重要,并可预防辐射诱导的胃肠道综合征。
健康与糖尿病状态下人类胰岛和腺泡内皮细胞的单细胞图谱
Nat Commun. 2025 Feb 6;16(1):1338. doi: 10.1038/s41467-024-55415-3.
4
Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models.在临床前胰腺癌模型中,抑制白血病抑制因子(LIF)和程序性死亡受体配体1(PD-L1)可增强化疗效果。
Cancers (Basel). 2025 Jan 9;17(2):204. doi: 10.3390/cancers17020204.
5
Dissecting the emerging role of cancer-associated adipocyte-derived cytokines in remodeling breast cancer progression.剖析癌症相关脂肪细胞来源的细胞因子在重塑乳腺癌进展中的新作用。
Heliyon. 2024 Jul 26;10(15):e35200. doi: 10.1016/j.heliyon.2024.e35200. eCollection 2024 Aug 15.
6
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis.对LIF/LIFR自分泌环的药理学抑制揭示了卵巢癌细胞对铁死亡的易感性。
NPJ Precis Oncol. 2024 May 24;8(1):118. doi: 10.1038/s41698-024-00612-y.
7
Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice.白血病抑制因子抑制肝从头脂肪生成并诱导小鼠恶病质。
Nat Commun. 2024 Jan 20;15(1):627. doi: 10.1038/s41467-024-44924-w.
8
p53 suppresses MHC class II presentation by intestinal epithelium to protect against radiation-induced gastrointestinal syndrome.p53 通过抑制肠道上皮细胞的 MHC II 类呈递来防止辐射诱导的胃肠道综合征。
Nat Commun. 2024 Jan 2;15(1):137. doi: 10.1038/s41467-023-44390-w.
9
Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases.白血病抑制因子,人类疾病治疗中具有双刃剑效应的分子。
Mol Ther. 2023 Feb 1;31(2):331-343. doi: 10.1016/j.ymthe.2022.12.016. Epub 2022 Dec 26.
10
O-GlcNAcylation in Renal (Patho)Physiology.O-连接的 N-乙酰氨基葡萄糖基化在肾脏(病理)生理学中的作用。
Int J Mol Sci. 2022 Sep 24;23(19):11260. doi: 10.3390/ijms231911260.
Cell Death Dis. 2020 Jul 27;11(7):588. doi: 10.1038/s41419-020-02790-6.
4
Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.Parkin 泛素化磷酸甘油酸脱氢酶以抑制丝氨酸合成和肿瘤进展。
J Clin Invest. 2020 Jun 1;130(6):3253-3269. doi: 10.1172/JCI132876.
5
Dietary Approaches to Cancer Therapy.癌症治疗膳食疗法。
Cancer Cell. 2020 Jun 8;37(6):767-785. doi: 10.1016/j.ccell.2020.04.005. Epub 2020 May 14.
6
Insulin-PI3K signalling: an evolutionarily insulated metabolic driver of cancer.胰岛素-PI3K 信号:癌症进化上隔离的代谢驱动因素。
Nat Rev Endocrinol. 2020 May;16(5):276-283. doi: 10.1038/s41574-020-0329-9. Epub 2020 Mar 3.
7
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.2-脱氧-D-葡萄糖及其类似物:从诊断试剂到治疗药物。
Int J Mol Sci. 2019 Dec 29;21(1):234. doi: 10.3390/ijms21010234.
8
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.致癌信号与癌症代谢交界处的 PI3K-AKT 网络。
Nat Rev Cancer. 2020 Feb;20(2):74-88. doi: 10.1038/s41568-019-0216-7. Epub 2019 Nov 4.
9
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.针对胰腺癌治疗和监测的 LIF 介导的旁分泌相互作用。
Nature. 2019 May;569(7754):131-135. doi: 10.1038/s41586-019-1130-6. Epub 2019 Apr 17.
10
Tumor suppressor p53 and metabolism.肿瘤抑制因子 p53 与代谢。
J Mol Cell Biol. 2019 Apr 1;11(4):284-292. doi: 10.1093/jmcb/mjy070.